AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deutschmann, H. A.
Right arrow Articles by Hausegger, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deutschmann, H. A.
Right arrow Articles by Hausegger, K. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Endoluminal Therapy in Patients with Peripheral Arterial Disease: Prospective Assessment of Quality of Life in 190 Patients

Hannes A. Deutschmann1, Helmut Schoellnast1, Werner Temmel1, Michael Deutschmann1, Gerold Schwantzer2, Gerald A. Fritz1, Marianne Brodmann3 and Klaus A. Hausegger4

1 Department of Radiology, Medical University Graz, University Hospital Graz, Auenbruggerplatz 9, Graz A-8036, Austria.
2 Institute of Medical Informatics, Statistics and Documentation, Medical University Graz, Graz, Austria.
3 Department of Angiology, Medical University Graz, University Hospital Graz, Graz, Austria.
4 Central Institute of Roentgendiagnostics, LKH, Klagenfurt, Austria.


Figure 1
View larger version (40K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 1 —Bar graph shows changes in mean short-form (36-item) health survey (SF-36) scores from before intervention to 1-, 3-, 6-, and 12-month follow-ups. Pre PTA/Stent = before percutaneous transluminal angioplasty or stent placement, PF = physical functioning, RP = role limitations due to physical problems, RE = role limitations due to emotional problems, VT = vitality, MH = mental health, SF = social functioning, BP = bodily pain, GH = general health.

 

Figure 2
View larger version (24K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 2 —Bar graph shows changes of short-form (36-item) health survey (SF-36) scores from before intervention to 1-, 3-, 6-, and 12-month follow-ups, shown as effect size. PF = physical functioning, RP = role limitations due to physical problems, RE = role limitations due to emotional problems, VT = vitality, MH = mental health, SF = social functioning, BP = bodily pain, GH = general health.

 

Figure 3
View larger version (13K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 3 —Bar graph shows mean short-form (36-item) health survey (SF-36) scores of claudicant patients (white bars) and patients with critical limb ischemia (black bars) at baseline. Asterisks show level of statistical significance as determined by Mann-Whitney U test: one asterisk, p < 0.05; two asterisks, p < 0.01. PF = physical functioning, RP = role limitations due to physical problems, RE = role limitations due to emotional problems, VT = vitality, MH = mental health, SF = social functioning, BP = bodily pain, GH = general health.

 

Figure 4
View larger version (12K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 4 —Bar graph shows changes of short-form (36-item) health survey (SF-36) scores from before intervention to 1-month follow-up, shown as effect size, in claudicant patients (white bars) and patients with critical limb ischemia (black bars). Asterisks show level of statistical significance as determined by Mann-Whitney U test to be p < 0.05. PF = physical functioning, RP = role limitations due to physical problems, RE = role limitations due to emotional problems, VT = vitality, MH = mental health, SF = social functioning, BP = bodily pain, GH = general health.

 

Figure 5
View larger version (11K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 5 —Bar graph shows changes of short-form (36-item) health survey (SF-36) scores from before intervention to 12-month follow-up, shown as effect size, in claudicant patients (white bars) and patients with critical limb ischemia (black bars). PF = physical functioning, RP = role limitations due to physical problems, RE = role limitations due to emotional problems, VT = vitality, MH = mental health, SF = social functioning, BP = bodily pain, GH = general health.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.